Apyx Medical Corporation

Stage 4 · Declining · week 8

As of Oct 22, 2026, Apyx Medical is in Stage 4, the downtrend phase, now in week 8 (since Sep 1, 2026). It closed at $2.41, 50.4% below its 52-week high and below its 200-day average, which is falling.

$2.41

-3.98% today

$102M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is APYX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 15w

S4 20w

S2 19w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S3 8w → S4 15w → S1 5w → S4 15w → S1 3w → S4 20w → S1 3w → S2 9w → S3 5w → S4 9w → S1 3w → S2 13w → S3 2w → S2 19w → S3 12w → S2 12w → S3 3w → S4 7w current

Total tracked: 165 weeks across 18 stage runs.

APYX among Medical Devices65th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…65	APYXApyx Medical Corporation	Stage 4 · wk 8	38	−18.3%

vs 52W High

-50.4%

$2.36 lo$4.86 hi

50.4% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 8

1w13w26w

Week 8, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-33.7%

200 DMA: $3.64 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.26x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-18.3%

-38.5%

-36.6%

YTD

-31.1%

-21.8%

Scan Membership

Breakout Watch

Latest: 2025-06-20

7 appearances in last 60 days. First seen: 2019-11-29.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 8 · Vol 1.26x

2026-10-21S4

Wk 8 · Vol 0.44x

2026-10-20S4

Wk 7 · Vol 2.48x

2026-10-19S4

Wk 7 · Vol 1.50x

2026-10-16S4

Wk 7 · Vol 0.36x

2026-10-15S4

Wk 7 · Vol 1.03x

2026-10-14S4

Wk 7 · Vol 0.26x

2026-10-13S4

Wk 6 · Vol 1.00x

2026-10-12S4

Wk 6 · Vol 0.54x

2026-10-09S4

Wk 6 · Vol 0.70x

2026-10-08S4

Wk 6 · Vol 1.61x

2026-10-07S4

Wk 6 · Vol 0.24x

Moving averages & range

50 DMA

$2.83

200 DMA

$3.64

52W High

$4.86

52W Low

$2.36

5D Low

$2.41

Resistance levels (recent highs)

20d High

$2.96

60d High

$4.28

120d High

$4.86

250d High

$4.86

Next resistance

+22.8%

to 20d High

ROE

-90.7%

Profit margin -14.8%

Dividend Yield

0.00%

P/B 9.5

Apyx Medical: quick answers

What stage is Apyx Medical in?

As of Oct 22, 2026, Apyx Medical (APYX) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 1, 2026 and is in week 8. What the four stages mean

Is Apyx Medical in an uptrend?

No. Apyx Medical is in a Stage 4 downtrend. It trades 33.7% below its 200-day average, which is falling.

How far is Apyx Medical from its 52-week high?

Apyx Medical closed at $2.41 on Oct 22, 2026, 50.4% below its 52-week high of $4.86. Its 52-week low is $2.36.

How has Apyx Medical performed over the past year?

As of Oct 22, 2026, Apyx Medical is down 21.8% over the past year and down 31.1% so far in 2026.

Which sector and industry is Apyx Medical in?

Apyx Medical is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.